Clariane SE (CHIX:CLARIP) Other Current Receivables: €265 Mil (As of Dec. 2025)


CHIX:CLARIP Clariane SE CHIX:CLARIP
63 GF Score
Price €4.13
GF Value €2.47
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Clariane SE Other Current Receivables?

Clariane SE CHIX:CLARIP 63 Other Current Receivables is €265 Mil as of Dec. 2025. GuruFocus rates CHIX:CLARIP with a GF Score™ of 63/100 and a GF Value™ of €2.47 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Clariane SE's Other Current Receivables for the quarter that ended in Dec. 2025 was €265 Mil.

Clariane SE's quarterly Other Current Receivables declined from Dec. 2024 (€361.64 Mil) to Jun. 2025 (€346.38 Mil) but then stayed the same from Jun. 2025 (€346.38 Mil) to Dec. 2025 (€264.89 Mil).

Clariane SE's annual Other Current Receivables declined from Dec. 2023 (€386.62 Mil) to Dec. 2024 (€361.64 Mil) and declined from Dec. 2024 (€361.64 Mil) to Dec. 2025 (€264.89 Mil).

Clariane SE Other Current Receivables Related Terms

Clariane SE Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Clariane SE's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clariane SE Other Current Receivables Chart

Clariane SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 261.61 224.78 386.62 361.64 264.89

Clariane SE Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 386.62 327.53 361.64 346.38 264.89
CHIX:CLARIP
63GF Score
Clariane SE CHIX:CLARIP
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clariane SE Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of €265 Mil mean?
Clariane SE (CHIX:CLARIP) has a Other Current Receivables of €265 Mil as of Dec. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Clariane SE and its competitors.
Is Clariane SE's Other Current Receivables too high?
Clariane SE's current Other Current Receivables is €265 Mil. Overall, Clariane SE has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clariane SE's Other Current Receivables compare to HCA and THC?
Clariane SE's Other Current Receivables of €265 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Healthcare Providers & Services company?
A good Other Current Receivables depends on the Healthcare Providers & Services industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Clariane SE and its competitors. Clariane SE's current Other Current Receivables is €265 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clariane SE stock overvalued right now?
Based on GuruFocus' analysis, Clariane SE (CHIX:CLARIP) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.47, compared to a current price of €4.13 — trading 67% above its estimated fair value. The current Other Current Receivables is €265 Mil. Clariane SE's overall GF Score™ is 63/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Clariane SE (CHIX:CLARIP), the current Other Current Receivables is €265 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clariane SE (CHIX:CLARIP) Overvalued in 2026?

Based on GuruFocus' analysis, Clariane SE stock appears to be overvalued. The current stock price of €4.13 is trading 67% above its estimated GF Value™ of €2.47. GuruFocus considers Clariane SE to be Significantly Overvalued.

Key valuation signals for CHIX:CLARIP:

  • Other Current Receivables: €265 Mil
  • GF Value™: €2.47 vs. price of €4.13 (67% above fair value)
  • GF Score™: 63/100 with 9 warning signs

No single metric tells the full story. See the CHIX:CLARIP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Clariane SE Business Description

Address 21-25, Rue Balzac, Paris, FRA, 75008
Clariane SE is a specialist in non-acute care and operates in two main areas: long-term care, through two forms of support, medicalized nursing homes offering specialty facilities accommodation and care for vulnerable older people and alternative living solutions, and specialty care activities such as specialty and post-acute , mental health and a number of medical, surgical and obstetrics clinics. Its segments include France, Germany, Benelux, Italy and Spain.
63GF Score

Get the complete analysis for CHIX:CLARIP

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.13
Price
€2.47
GF Value